Victory Capital Management Inc Mersana Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 11,458 shares of MRSN stock, worth $18,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,458

Previous 11,873 3.5%

Holding current value

$18,561

Previous $23,000 8.7%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$1.23 - $2.25 $510 - $933	-415 Reduced 3.5%	11,458 $21,000
Q2 2024 Aug 05, 2024	SELL	$2.0 - $4.45 $428 - $952	-214 Reduced 1.77%	11,873 $23,000
Q1 2024 May 03, 2024	SELL	$2.16 - $5.94 $1,393 - $3,831	-645 Reduced 5.07%	12,087 $54,000
Q4 2023 Feb 05, 2024	BUY	$1.11 - $2.34 $14,132 - $29,792	12,732 New	12,732 $29,000
Q2 2022 Aug 01, 2022	BUY	$2.84 - $5.0 $6,461 - $11,375	2,275 Added 22.17%	12,537 $58,000
Q1 2022 May 04, 2022	BUY	$3.74 - $6.63 $38,379 - $68,037	10,262 New	10,262 $36,000
Q2 2021 Aug 03, 2021	SELL	$13.28 - $18.07 $250,686 - $341,107	-18,877 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$15.31 - $26.52 $163,357 - $282,968	-10,670 Reduced 36.11%	18,877 $305,000
Q4 2020 Feb 01, 2021	BUY	$16.84 - $27.59 $169,814 - $278,217	10,084 Added 51.81%	29,547 $786,000
Q3 2020 Nov 09, 2020	BUY	$16.2 - $25.7 $167,589 - $265,866	10,345 Added 113.46%	19,463 $362,000
Q2 2020 Aug 07, 2020	BUY	$5.24 - $23.4 $18,911 - $84,450	3,609 Added 65.51%	9,118 $213,000
Q1 2020 May 04, 2020	SELL	$4.41 - $9.28 $3,761 - $7,915	-853 Reduced 13.41%	5,509 $32,000
Q4 2019 Feb 04, 2020	SELL	$1.45 - $6.73 $118 - $551	-82 Reduced 1.27%	6,362 $43,000
Q3 2019 Nov 12, 2019	BUY	$1.54 - $4.2 $9,923 - $27,064	6,444 New	6,444 $10,000
Q1 2018 May 04, 2018	SELL	$13.56 - $18.48 $785,530 - $1.07 Million	-57,930 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$14.95 - $19.9 $85,663 - $114,026	5,730 Added 10.98%	57,930 $952,000
Q3 2017 Oct 27, 2017	SELL	$14.8 - $18.06 $26,640 - $32,507	-1,800 Reduced 3.33%	52,200 $903,000
Q2 2017 Aug 07, 2017	BUY	N/A	54,000	54,000 $754,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $157M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Mersana Therapeutics, Inc. Transaction History